HISTOPLASMOSIS

Clinical trials for HISTOPLASMOSIS explained in plain language.

Never miss a new study

Get alerted when new HISTOPLASMOSIS trials appear

Sign up with your email to follow new studies for HISTOPLASMOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

One-Shot vs. daily doses: trial aims to simplify serious fungal infection treatment

Disease control Not yet recruiting

This study aims to find better ways to treat moderate to severe histoplasmosis, a serious fungal infection. It will test if a single high-dose intravenous treatment works as well as the standard daily lower doses. It will also test if a newer oral drug (posaconazole) or a shorter…

Matched conditions: HISTOPLASMOSIS

Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

HISTOPLASMOSIS

Get alerted when new HISTOPLASMOSIS trials appear

One-Shot vs. daily doses: trial aims to simplify serious fungal infection treatment